The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Keeps Halo Pharma to drive independent growth
The agreement could rise to $900 million if key commercial milestones are met
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
India in the Changing Landscape of Life-Sciences Research & Development
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
